文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型冠状病毒病2019相关急性呼吸窘迫综合征患者肺栓塞的相关因素:375例多中心研究

Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients.
PubMed 文献 · Crit Care Explor · 2020-06-25
一句话结论在COVID-19中重度ARDS患者中,28天时15%诊断肺栓塞,年轻年龄(<65岁)、症状出现至抗病毒治疗时间≥7天及神经肌肉阻滞剂使用≥7天与肺栓塞独立相关。

该研究为COVADIS项目的事后分析,纳入法国12个和比利时9个ICU共375例连续的中重度COVID-19 ARDS患者。第28天时15%的患者诊断肺栓塞。已知肺栓塞危险因素(癌症、肥胖、糖尿病、高血压、冠心病)与肺栓塞无关联。多因素分析显示,年龄<65岁(OR 2.14;作者认为这些新发现强调需要前瞻性研究来确定重型COVID-19患者肺栓塞的预测因素。

要点

  • 在21个ICU的375例中重度COVID-19 ARDS患者中,第28天15%诊断肺栓塞。
  • 已知肺栓塞危险因素(癌症、肥胖、糖尿病、高血压、冠心病)与肺栓塞无关联。

适用人群与场景

  • 法国(n = 12)和比利时(n = 9)共21个ICU连续纳入的375例中重度急性呼吸窘迫综合征且COVID-19阳性的患者。

研究设计与关键结果

  • 研究类型为COVADIS项目的事后分析,该项目的多中心观察性研究纳入法国(n = 12)和比利时(n = 9)共21个ICU的375例连续中重度COVID-19 ARDS患者。
  • 第28天时15%的患者诊断肺栓塞。
  • 已知肺栓塞危险因素包括癌症、肥胖、糖尿病、高血压和冠心病,均与肺栓塞无关联。

证据类型、等级与局限

  • 证据类型:多中心观察性研究(COVADIS项目)的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些新发现强调需要前瞻性研究来确定重型COVID-19患者肺栓塞的预测因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 9 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

Risk factors associated with pulmonary embolism in coronavirus disease 2019 acute respiratory distress syndrome patients deserve to be better known. We therefore performed a post hoc analysis from the COronaVirus-Associated DIsease Study (COVADIS) project, a multicenter observational study gathering 21 ICUs from France (n = 12) and Belgium (n = 9). Three-hundred seventy-five consecutive patients with moderate-to-severe acute respiratory distress syndrome and positive coronavirus disease 2019 were included in the study. At day 28, 15% were diagnosed with pulmonary embolism. Known risk factors for pulmonary embolism including cancer, obesity, diabetes, hypertension, and coronary artery disease were not associated with pulmonary embolism. In the multivariate analysis, younger age (< 65 yr) (odds ratio, 2.14; 1.17-4.03), time between onset of symptoms and antiviral administration greater than or equal to 7 days (odds ratio, 2.39; 1.27-4.73), and use of neuromuscular blockers greater than or equal to 7 days (odds ratio, 1.89; 1.05-3.43) were independently associated with pulmonary embolism. These new findings reinforce the need for prospective studies that will determine the predictors of pulmonary embolism among patients with severe coronavirus disease 2019.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Soumagne T, Lascarrou JB, Hraiech S, et al. Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients. Crit Care Explor. 2020. PMID: 32766562. doi:10.1097/CCE.0000000000000166

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。